Wellness

  • FDA approves new menopause drug to treat hot flashes and night sweats

    The FDA has approved elinzanetant, a new non-hormonal treatment for menopause that reduces hot flushes and night sweats. Clinical trials in the US, Europe and Israel found the drug significantly reduced both the frequency and severity of hot flushes while improving women’s sleep and quality of life. The approval follows successful results from the double-blind [...]

  • Air pollution may increase breast cancer risk, study suggests

    Long-term exposure to air pollution may increase the risk of breast cancer, with a study of more than 400,000 women showing higher rates in areas with poor air quality. Researchers tracked 28,000 breast cancer cases over several decades, following participants for up to 10 years before diagnosis and monitoring changes in their home addresses. They [...]

  • Melinda French Gates-backed startup Tia cuts 23% of staff

    Women’s healthcare company Tia, backed by Melinda French Gates, has cut 72 jobs, reducing its workforce by 23 per cent across corporate and clinical divisions. Chief executive Felicity Yost told staff on Monday that the company would downsize as part of a plan to accelerate its path to profitability, according to Business Insider. The cuts [...]

  • Menopause Society receives US$5m for digital training

    The Menopause Society has secured US$5m from the Steven & Alexandra Cohen Foundation to develop digital training for healthcare professionals. The grant will fund the digital-innovation phase of the NextGen Now initiative, which aims to build a digital ecosystem using advanced technologies to improve education on women’s health in midlife. Launched in June, the initiative [...]

  • Spain faces protests over mammogram scandal

    Thousands of people protested in Seville on Sunday after revelations that 2,300 women were not given the results of mammogram tests showing abnormalities that required follow-up care. The demonstrations targeted Andalusia’s regional government after it emerged that women who had mammograms – X-ray scans used to detect breast cancer – at public hospitals in recent [...]

  • Bayer wins US approval for menopause drug

    Bayer has received US approval for its non-hormonal drug to relieve hot flushes linked to menopause. The US Food and Drug Administration (FDA) has approved Lynkuet for treating moderate to severe vasomotor symptoms – also known as hot flushes – associated with menopause. The approval was based on three late-stage studies that showed Lynkuet reduced [...]

  • Testosterone patch shows promise for menopausal women

    A new testosterone patch has shown positive results in initial Phase 1 clinical testing, offering renewed hope for women seeking hormone therapy. Drug delivery firm Medherant has announced encouraging findings from its Phase 1 trial of the TEPI Patch, carried out at Hammersmith Medicines Research (HMR) in London. The study found that the patch effectively [...]

  • Women’s health is not niche: It’s the future of healthcare

    By Melissa Wallace, CEO & Founding Partner of Fierce Foundry Just a few years ago, so many conversations around women’s health in the U.S. felt like they were still just making the case for why investment mattered. Panels, white papers, TED-style talks pointed to under-funding, data gaps, structural bias. But something has shifted. Across healthcare [...]

  • ChatGPT can safely guide pregnant women treated for opioid use, study finds

    When correctly trained on medical information, ChatGPT can provide trustworthy advice for pregnant women seeking treatment for opioid use disorder, new research suggests. The findings could inform the development of digital tools such as apps and websites for people looking for medical guidance on sensitive issues they may not wish to discuss face to face [...]

  • SheMed raises €43m to scale UK operations

    London-based women’s health platform SheMed has raised €43m to expand its UK operations and further develop its personalised healthcare platform. The company, founded by sisters Olivia and Chloe Ferro in April 2024, will use the investment to scale its medical and technology teams, strengthen clinical infrastructure and enhance its data-driven systems. SheMed offers weight management [...]